Lifted By Higher Product Sales, Amgen Beats Consensus EPS April 25, 2005 Beating Wall Street estimates, Amgen Inc. performed well in the first quarter, reporting strong revenue for most of its products, despite Medicare reimbursement changes. (BioWorld Today)Read More
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Feb. 17-April 20, 2005 April 25, 2005
RSS